AbbVie Inc.
Market Cap
$392.72B
P/E Ratio
93.72
EPS
$2.37
Dividend Yield
2.89%
52-Week Range
$164.39 — $244.81
Volume
1.49M
Avg Volume
6.81M
Beta
0.33
P/E (TTM)
93.72
Forward P/E
15.29
PEG Ratio
1.24
P/S (TTM)
6.65
P/B (TTM)
-125.29
P/FCF
0.00
EV/EBITDA
0.00x
EV/Sales
—
ROE (TTM)
-3.62%
ROA (TTM)
0.03%
ROIC
0.00%
Gross Margin
0.73%
Operating Margin
0.27%
Net Margin
0.11%
Debt/Equity
-21.06
Current Ratio
0.67
EPS Growth (YoY)
+83.02%
Revenue Growth (YoY)
+0.09%
EPS Growth (3Y)
-0.24%
EPS Growth (5Y)
+0.14%
Sales Growth (3Y)
+0.02%
Sales Growth (5Y)
+0.06%
EPS Est (This Year)
$14.53
EPS Est (Next Year)
$16.11
Dividend Yield
—
Annual Dividend
$1.64
Payout Ratio
1.61%
Frequency
—
Ex-Dividend Date
2025-10-15
Cash/Share
$2.95
Price Target Range
Consensus Target: $255.83(15.2% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.77B
Float
1.76B
Free Float %
99.81%
RSI (14)
44.97
SMA 20
$228.60
SMA 50
$225.02
SMA 200
$215.13
ATR (14)
5.95
Volatility (Week)
0.01%
Volatility (Month)
0.01%
Pattern
—
1 Day
-1.18%
1 Week
-2.93%
1 Month
+3.82%
3 Months
-0.58%
6 Months
+6.98%
1 Year
—
YTD
-0.84%
All-Time High
$244.81
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
US
Exchange
NYSE
IPO Date
2013-01-02
Employees
55000
CEO
Robert A. Michael
Index Membership
S&P 500
Website
https://www.abbvie.com
AbbVie Inc. (ABBV) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $392.72B, a P/E ratio of 93.72, and a dividend yield of 2.89%, ABBV is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ABBV against other stocks using dozens of fundamental and technical filters.
AbbVie Inc. (ABBV) has a trailing twelve-month (TTM) P/E ratio of 93.72. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, AbbVie Inc. (ABBV) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
AbbVie Inc. (ABBV) has a market capitalization of $392.72 billion, classifying it as a mega-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
AbbVie Inc. (ABBV) has returned -0.84% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.